172 related articles for article (PubMed ID: 26050269)
21. Recommended composition of influenza vaccines for use in the 2012 southern hemisphere influenza season.
Wkly Epidemiol Rec; 2011 Oct; 86(42):457-68. PubMed ID: 22046594
[No Abstract] [Full Text] [Related]
22. Recommended composition of influenza virus vaccines for use in the 2016 southern hemisphere influenza season.
Wkly Epidemiol Rec; 2015 Oct; 90(41):545-59. PubMed ID: 26454888
[No Abstract] [Full Text] [Related]
23. Recommended composition of influenza virus vaccines for use in the 2006-2007 influenza season.
Wkly Epidemiol Rec; 2006 Mar; 81(9):82-6. PubMed ID: 16671218
[No Abstract] [Full Text] [Related]
24. Recommended composition of influenza virus vaccines for use in the 2014 southern hemisphere influenza season.
Wkly Epidemiol Rec; 2013 Oct; 88(41):437-48. PubMed ID: 24159667
[No Abstract] [Full Text] [Related]
25. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere season.
Barr IG; McCauley J; Cox N; Daniels R; Engelhardt OG; Fukuda K; Grohmann G; Hay A; Kelso A; Klimov A; Odagiri T; Smith D; Russell C; Tashiro M; Webby R; Wood J; Ye Z; Zhang W;
Vaccine; 2010 Feb; 28(5):1156-67. PubMed ID: 20004635
[TBL] [Abstract][Full Text] [Related]
26. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
[TBL] [Abstract][Full Text] [Related]
27. Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies.
Rondy M; Kissling E; Emborg HD; Gherasim A; Pebody R; Trebbien R; Pozo F; Larrauri A; McMenamin J; Valenciano M;
Euro Surveill; 2018 Mar; 23(9):. PubMed ID: 29510782
[TBL] [Abstract][Full Text] [Related]
28. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
[TBL] [Abstract][Full Text] [Related]
29. Possible reduced effectiveness of the 2009 H1N1 component of live, attenuated influenza vaccine.
Myers CA; Faix DJ; Blair PJ
Clin Infect Dis; 2011 Jul; 53(2):207-8. PubMed ID: 21690631
[No Abstract] [Full Text] [Related]
30. Recommended composition of influenza virus vaccines for use in the 2007-2008 influenza season.
Wkly Epidemiol Rec; 2007 Mar; 82(9):69-74. PubMed ID: 17333570
[No Abstract] [Full Text] [Related]
31. Review of the 2015 influenza season in the southern hemisphere.
Wkly Epidemiol Rec; 2015 Nov; 90(48):645-60. PubMed ID: 26619519
[No Abstract] [Full Text] [Related]
32. Recommended composition of influenza virus vaccines for use in the 2008 influenza season.
Wkly Epidemiol Rec; 2007 Oct; 82(40):351-6. PubMed ID: 17918656
[No Abstract] [Full Text] [Related]
33. Review of the 2012 winter influenza season, southern hemisphere.
Wkly Epidemiol Rec; 2012 Nov; 87(44):422-31. PubMed ID: 23139951
[No Abstract] [Full Text] [Related]
34. Review of the 2013 influenza season in the southern hemisphere.
Wkly Epidemiol Rec; 2013 Nov; 88(48):509-20. PubMed ID: 24367834
[No Abstract] [Full Text] [Related]
35. Recommended composition of influenza virus vaccines for use in the 2008-2009 influenza season.
Wkly Epidemiol Rec; 2008 Feb; 83(9):81-7. PubMed ID: 18309579
[No Abstract] [Full Text] [Related]
36. Evaluation of Southern Hemisphere influenza vaccine recommendations.
Richard SA; Viboud C; Miller MA
Vaccine; 2010 Mar; 28(15):2693-9. PubMed ID: 20153352
[TBL] [Abstract][Full Text] [Related]
37. Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe.
Broberg E; Melidou A; Prosenc K; Bragstad K; Hungnes O;
Euro Surveill; 2016; 21(13):. PubMed ID: 27074657
[TBL] [Abstract][Full Text] [Related]
38. Recommended composition of influenza virus vaccines for use in the 2007 influenza season.
Wkly Epidemiol Rec; 2006 Oct; 81(41):390-5. PubMed ID: 17039626
[No Abstract] [Full Text] [Related]
39. Epidemiological and genetic characterization of pH1N1 and H3N2 influenza viruses circulated in MENA region during 2009-2017.
Al Khatib HA; Al Thani AA; Gallouzi I; Yassine HM
BMC Infect Dis; 2019 Apr; 19(1):314. PubMed ID: 30971204
[TBL] [Abstract][Full Text] [Related]
40. Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019.
Kissling E; Rose A; Emborg HD; Gherasim A; Pebody R; Pozo F; Trebbien R; Mazagatos C; Whitaker H; Valenciano M;
Euro Surveill; 2019 Feb; 24(8):. PubMed ID: 30808440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
